Mono Propylene Glycol (E1520) CAS: 57-55-6
Related Insights
PCS Singapore Force Majeure Wind-Down Status: What the Latest Market Developments Mean for Petrochemical Buyers
Recent geopolitical developments have renewed attention on PCS Singapore's force majeure position and its implications for regional petrochemical supply. Buyers of polyethylene, polypropylene and ethylene derivatives should reassess supplier communication and supply chain contingency plans.
Using the Kiel Institute to Separate Temporary Hormuz Costs from Permanent Chemical Procurement Shifts
After the Hormuz shutdown, chemical buyers face a mix of temporary price spikes and lasting market shifts. This article applies the Kiel Institute framework to isolate recoverable costs from permanent baseline changes, providing a roadmap for data‑driven contract renegotiations. Implementing these insights helps teams win back margins as conditions normalize.
Ras Laffan Attack Damage and the 3 to 5 Year Impact on Pharmaceutical Helium Supply
Damage at Qatar's Ras Laffan Industrial City could reshape the pharmaceutical helium market for years. Procurement teams should prepare for tighter supply, higher sourcing risks and changing global trade patterns.
Sorbitol: China's Old-Crop Supply Window and Why July Is the Contracting Sweet Spot
July 2026 presents a rare procurement opportunity for sorbitol buyers as stable Chinese feedstock costs, Thailand’s seasonal production gap, and easing freight rates combine to create one of the most attractive contracting windows of H2. Buyers with second-half demand requirements should act before supplier
Force Majeure Close-Out Documentation: The Legal Checklist for Chemical Supply Agreements
As Gulf supply chains begin physically recovering (34 Kpler crossings June 30), the commercial and legal process of formally closing
Glycerin Pharmaceutical Grade: H1 Closing Review of EUDR and Supply Chain Challenges
Pharmaceutical-grade glycerin enters H2 2026 at the intersection of supply chain recovery and evolving sustainability regulations. Pharmaceutical buyers must balance USP/EP quality requirements with EUDR compliance while diversifying sourcing strategies.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.